GlobeNewswire

Nancy J. Sandy Appointed Chief Executive Officer of Taconic Biosciences

Share

RENSSELAER, N.Y., Jan. 31, 2019 (GLOBE NEWSWIRE) -- Taconic Biosciences’ Board of Directors has selected Nancy J. Sandy to succeed Dr. Robert J. Rosenthal as Chief Executive Officer (CEO). Effective January 14, Ms. Sandy took the company’s top leadership position. Dr. Rosenthal, who held the position for four and a half years, continues his association with Taconic, leading external growth initiatives as Chief Innovation Officer and holds positions on the Taconic Scientific Advisory Board and Board of Directors. 

Ms. Sandy joined Taconic in January 2016, progressing through roles as Senior Vice President of Product Strategy and Marketing, Chief Operating Officer, and President before being named CEO. She led corporate initiatives to streamline operations, align internal teams, strengthen Taconic’s culture, and drive growth in both revenue and profitability. Prior to joining Taconic, Ms. Sandy held marketing leadership roles at several life science and medical device companies, including Perkin Elmer, Magellan Biosciences, and Cardiac Science. She holds both Bachelor of Arts in journalism and Master of Business Administration degrees from the University of Wisconsin at Madison. 

“Nancy’s strong leadership, commitment to excellence, and proven record with Taconic position her well to take on the CEO role. Additionally, we are pleased to continue to benefit from Bob’s expertise in his new capacity. We are excited by this seamless transition and are proud of our talented leadership team, which will serve to strengthen the company now and in the future,” commented Kathrin Phelan Midgley, chairman of Taconic Biosciences Board of Directors.

Ms. Sandy reflects on her time with Taconic, “my past three years with Taconic have been marked by incredible energy, change, and progress. The company has truly evolved from Taconic Farms to a world-class life sciences company. Combining our passion for excellence with over 65 years providing the best research model solutions allows us to help our customers solve complex research problems enabling them to accelerate advancements in human health. I am honored to have the opportunity to lead Taconic during this exciting next chapter.”

To learn more about Taconic's research model solutions, please contact Taconic Biosciences at 1-888-TACONIC (888-822-6642) in the US, +45 70 23 04 05 in Europe, or email info@taconic.com.

About Taconic Biosciences, Inc.
Taconic Biosciences is a fully-licensed, global leader in genetically engineered research models and services. Founded in 1952, Taconic provides the best solutions so that customers can acquire, custom generate, breed, precondition, test, and distribute valuable research models worldwide. Specialists in genetically engineered models, and integrated model design and breeding services, Taconic operates three service laboratories and six breeding facilities in the U.S. and Europe, maintains distributor relationships in Asia and has global shipping capabilities to provide animal models almost anywhere in the world.

Media Contact:
Kelly Owen Grover
Director of Marketing Communications
(518) 697-3824
kelly.grover@taconic.com

About GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire

Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire

Nordic American Tankers Limited (NYSE:NAT) - Commencement of Time Charter with major energy company Equinor. The TC has now started.22.8.2019 15:14:00 CESTPress release

Hamilton, Bermuda, August 22, 2019 Dear Shareholders, Earlier this year, we informed you of the Time Charter we have entered into of 12 to 15 months. Please note that the Time Charter has now started. CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS Matters discussed in this press release may constitute forward-looking statements. The Private Securities Litigation Reform Act of 1995 provides safe harbor protections for forward-looking statements in order to encourage companies to provide prospective information about their business. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements, which are other than statements of historical facts. The Company desires to take advantage of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and is including this cautionary statement in connection with this safe harbor legislation. The words

Interim financial statement of Arion Bank Mortgages Institutional Investor Fund (ABMIIF) for 201922.8.2019 12:33:00 CESTPress release

The institutional investor fund ABMIIF, which is managed by Stefnir hf, issued bonds which were admitted to trading on NASDAQ OMX Iceland hf. in 2014. The fund reported annual earnings of ISK 258 million according to the income statement and the earnings are stated as an increase in units in the fund’s accounts. The net assets of the fund at the end of June 2019 totalled ISK 18.386 million according to the balance sheet. The interim financial statement was audited by Deloitte ehf. in accordance with international standards on auditing. It is the auditor’s opinion that the interim financial statement gives a clear picture of the performance of the fund in the first half of 2019, its financial position as of 30 June 2019 and changes in the fund's net assets in the first half of 2019 in accordance with the Annual Accounts Act and the regulations on the financial statements of management companies of UCITS set by the Icelandic Financial Supervisory Authority. On the 8th of August Arion Ban

Avance Gas Holding Ltd - Q2 2019 Presentation22.8.2019 11:14:00 CESTPress release

Avance Gas Holding Ltd - Q2 2019 Presentation Please find enclosed the presentation of Avance Gas Holding Ltd (OSE: AVANCE) for the second quarter 2019 results to be held on the webcast/conference call 22 August, 2019 at 15:00 CET. Attend by webcast: https://edge.media-server.com/mmc/p/ai3j273v Attend by conference call: UK and International: +44 (0) 2071 928 000 US: +1 631 510 7495 Norway: +47 23 96 02 64 Confirmation code: 3835678 For further queries, please contact: Peder C. G. Simonsen, CFO Tel: +47 22 00 48 15 Email: p.simonsen@avancegas.com ABOUT AVANCE GAS Avance Gas Holding Ltd operates in the global market for transportation of liquefied petroleum gas (LPG). The Company is one of the world's leading owners and operators of very large gas carriers (VLGCs), operating a fleet of 14 modern VLGC. For more information about Avance Gas, please visit: www.avancegas.com This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading

Change in Valmet Oyj’s holding of treasury shares22.8.2019 10:15:00 CESTPress release

Valmet Oyj’s stock exchange release on August 22, 2019 at 11:15 a.m. EET On August 22, 2019 a total of 389 Valmet shares have been returned free of consideration to Valmet Oyj according to the terms and conditions of the long-term incentive plan 2018-2020. Originally, the shares were transferred to the participants after the 2018 performance period of the plan. Including the returned shares, Valmet Oyj now holds a total of 245,624 treasury shares. Further information, please contact: Calle Loikkanen, Director, Investor Relations, Valmet, tel. +358 10 672 0020 VALMET Kari Saarinen CFO Calle Loikkanen Director, Investor Relations Valmet is the leading global developer and supplier of process technologies, automation and services for the pulp, paper and energy industries. We aim to become the global champion in serving our customers. Valmet’s strong technology offering includes pulp mills, tissue, board and paper production lines, as well as power plants for bioenergy production. Our adva

Result of Riksbank reversed auctions SEK bonds22.8.2019 10:07:00 CESTPress release

Auction date 2019-08-22 Loan 1058 Coupon 2.50 % ISIN-code SE0005676608 Maturity 2025-05-12 Tendered volume, SEK mln 500 +/- 250 Volume offered, SEK mln 1,850 Volume bought, SEK mln 500 Number of bids 5 Number of accepted bids 1 Average yield -0.588 % Lowest accepted yield -0.588 % Highest yield -0.588 % % accepted at lowest yield 100.00 Auction date 2019-08-22 Loan 1061 Coupon 0.75 % ISIN-code SE0011281922 Maturity 2029-11-12 Tendered volume, SEK mln 500 +/- 250 Volume offered, SEK mln 2,150 Volume bought, SEK mln 500 Number of bids 6 Number of accepted bids 2 Average yield -0.298 % Lowest accepted yield -0.298 % Highest yield -0.298 % % accepted at lowest yield 50.00 Auction date 2019-08-22 Loan 1058 Coupon 2.50 % ISIN-code SE000x5676608 Maturity 2025-05-12 Tendered volume, SEK mln 500 +/- 250 Volume offered, SEK mln X,XXX Volume bought, SEK mln X,XXX Number of bids XX Number of accepted bids XX Average yield X.XXX Lowest accepted yield X.XXX Highest yield X.XXX % accepted at lowest y

FRO - Invitation to Q2 2019 Results Conference Call and Webcast22.8.2019 10:06:00 CESTPress release

Frontline Ltd.’s preliminary second quarter 2019 results will be released on Tuesday August 27 2019, and a webcast and conference call will be held at 3:00 p.m. CET (9:00 a.m. U.S. Eastern Time). The results presentation will be available for download from the Investor Relations section at www.frontline.bm ahead of the conference call. In order to attend the conference call you may do one of the following: a. Webcast Go to the Investor Relations section at www.frontline.bm and follow the “Webcast” link. b. Conference Call Participant dial-in telephone numbers: Norway +47 2156 3162 Norway toll free 800 10392 UK +44 (0) 203 009 5710 UK Toll Free 0 800 376 7425 USA +1 917 720 0178 USA Toll Free 866 869 2321 Conference ID 8688637 Participants will be asked for their full name & Conference ID. A Q&A session will be held after the teleconference/webcast. Information on how to submit questions will be given at the beginning of the session. The presentation material which will be used in the t